Global Health Limited has informed the Exchange that Board of Directors at its meeting held on May 15, 2025, recommended Final Dividend of Rs. 0.50 per equity share.
MEDANTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.4 pts less than Nifty Midcap 150 and 2.7 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Global Health Limited (operator of Medanta hospitals) held a board meeting on May 15, 2025 and approved audited financial results for Q4 and FY ended March 31, 2025. The board recommended a final dividend of Rs. 0.50 per equity share (25% on face value of Rs. 2), subject to shareholder approval at the upcoming AGM. Standalone revenue from operations rose to Rs. 32,041 million in FY25 from Rs. 29,747 million in FY24 (restated), while standalone profit after tax dipped to Rs. 4,615 million from Rs. 4,863 million due to a one-time Rs. 498.96 million stamp duty charge on its merger with Medanta Holdings. Consolidated revenue grew to Rs. 36,921 million and consolidated PAT to Rs. 4,813 million. The board also appointed Dr. Pankaj Dhamija as Hospital Director for the Gurugram unit.
A modest dividend payout signals capital is being prioritised for expansion, with new hospital projects announced in Mumbai, Pitampura (Delhi), Ranchi, and Guwahati. The merger-related stamp duty weighed on standalone earnings, but consolidated growth and ongoing capacity additions are likely the focus for investors. Stock may see limited immediate reaction to the small dividend but expansion announcements could support longer-term sentiment.